HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SNWV
SANUWAVE Health Inc.
SNWV's fundamentals are mixed: it returned to profit, but its operating margin went from 17% to −1.1%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SNWV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
SNWV's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SNWV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 1.2x | $1.58 | — |
| Current | 4.3x | $1.58 | — |
| Cheap | 4.4x | $1.63 | +3.2% |
| Fair | 4.9x | $1.81 | +15% |
| Expensive | 5.7x | $2.10 | +33% |
Historical ranges are pointers, not guarantees.
SNWV's PE is 4.3x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SNWV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SNWV's earnings to grow and its profitability to improve, but its revenue to decline.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
SNWV has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus SNWV down 90%.
SNWV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.28 | +247% |
| Q3 2024 | $4.76 | +$31.01 |
| Q2 2024 | $0.00 | +$15.00 |
| Q1 2024 | -$3.75 | +$7.50 |
| Q4 2023 | -$11.25 | -$3.75 |
| Q3 2023 | -$26.25 | -$18.75 |
| Q2 2023 | -$15.00 | -$3.75 |
| Q1 2023 | -$11.25 | +$7.50 |
| Q4 2022 | -$7.50 | +$11.25 |
SNWV has returned to profit: it earned $0.37 per share over the past year, after losing money the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SNWV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SNWV on profitability, with a higher operating margin.
SNWV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6M | -25% |
| Q2 2026 | $9.7M | -4.2% |
| Q1 2026 | $9.6M | +3% |
| Q4 2025 | $13.4M | +30% |
| Q3 2025 | $11.5M | +22% |
| Q2 2025 | $10.2M | +42% |
| Q1 2025 | $9.3M | +61% |
| Q4 2024 | $10.3M | +48% |
SNWV's revenue has held roughly level: $9M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | -25 points |
| Q2 2026 | -2.9% | -21 points |
| Q1 2026 | -12% | -22 points |
| Q4 2025 | 15% | -9.5 points |
| Q3 2025 | 13% | -8.1 points |
| Q2 2025 | 18% | -9.3 points |
| Q1 2025 | 11% | +29 points |
| Q4 2024 | 24% | +9.6 points |
SNWV's operating margin was −13% last quarter, down 25 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SNWV on cash flow, with more consistent year-over-year improvement.
SNWV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -296% |
| Q2 2026 | $91K | +$257K |
| Q1 2026 | $374K | +$2.1M |
| Q4 2025 | $3.2M | +538% |
| Q3 2025 | $556K | -55% |
| Q2 2025 | -$166K | +$594K |
| Q1 2025 | -$1.7M | -270% |
| Q4 2024 | $505K | +$1.8M |
SNWV's free cash flow has turned positive after six years mostly in the red: $3M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SNWV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SNWV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.1K shares |
| 1 year | -5.9% | -538K shares |
| 3 years | +487% | +7.1M shares |
| 5 years | +739% | +7.6M shares |
SNWV has 9M diluted shares, down 5.9% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SNWV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -8.0x | Net Cash |
| Q2 2026 | -2.8x | Net Cash |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q3 2024 | 0.9x | Very low |
SNWV has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SNWV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.2 | Oversold |
| Stochastic | 16.7 | Oversold |
SNWV's weekly RSI is 24 (oversold) and its Stochastic is 17 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SNWV PE vs Healthcare Sector
| Metric | SNWV | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 26x | 83% below |
| PE % | 12 | 29 | 17 pts below |
SNWV is trading at 4.3x earnings, a 83% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SNWV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.32 | 63% below |
| 20 week MA | $5.42 | 71% below |
| 50 week MA | $15.2 | 90% below |
| 100 week MA | $23.5 | 93% below |
| 200 week MA | $16.3 | 90% below |
SNWV is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over SNWV on returns for 2026, with the stronger performance.
SNWV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.9 | $79.7 | +29% |
| 2021 | $79.7 | $56.3 | -29% |
| 2022 | $56.3 | $10.5 | -81% |
| 2023 | $10.5 | $4.87 | -54% |
| 2024 | $4.87 | $23.0 | +371% |
| 2025 | $23.0 | $30.5 | +33% |
| 2026 YTD | $30.5 | $1.58 | -95% |
SNWV's yearly returns have swung widely, from +371% in 2024 to −81% in 2022. It's down 95% so far in 2026.